Portfolio Execution Reviews for PE, Growth & VC Investors
Understand What Is Really Driving Underperformance Before Making a Critical Portfolio Decision
An independent review of the leadership, organizational and execution factors behind portfolio company performance.
A portfolio company is not delivering what was expected. The immediate temptation is often to change the CEO, reorganize the business or launch another performance plan.
But underperformance rarely has a single cause.
Leadership limitations, unclear priorities, governance tensions, organizational bottlenecks, weak management depth or execution discipline can reinforce one another.
A Portfolio Execution Review provides investors and Boards with an independent view of what is really happening before a critical decision is made.
The objective is to distinguish symptoms from root causes, identify the issues that materially affect value creation and clarify where action should begin.
When Investors Call Us
The symptoms are visible, but the real cause and the right response are not yet clear.
- The company repeatedly misses its plan.
- Growth has slowed or plateaued.
- Margins or operational performance are deteriorating.
- Execution varies significantly across functions or business units.
- Corrective initiatives are not producing the expected results.
- Investors are questioning the CEO or executive team.
- The CEO appears overloaded or has become a bottleneck.
- The executive team is fragmented or ineffective.
- Board discussions have become repetitive or tense.
- Investors and management no longer share the same diagnosis.
- A CEO or leadership change is being considered.
- The organization may need to be redesigned.
- Governance may need to evolve.
- A major transformation or turnaround decision is required.
- Investors want an independent perspective before acting.
The Questions We Help Answer
The review starts with the decisions investors and Boards may need to make.
- Why is the company not delivering its plan?
- Is the CEO the main issue, or is the problem broader?
- Can the current executive team execute the investment thesis?
- Is the strategy sufficiently clear and translated into priorities?
- Has the organization become a constraint on performance?
- Are governance and decision-making helping or slowing execution?
- Where are the critical organizational bottlenecks?
- Which capabilities or leaders need to be strengthened?
- What can be corrected without destabilizing the company?
- Does the leadership team need to be reinforced or reconfigured?
- Which issues require immediate action and which can wait?
- What should investors monitor over the next six to twelve months?
What We Review
We connect four dimensions to understand why execution is succeeding or failing.
Can the CEO and executive team deliver?
CEO effectiveness, executive-team capability, role fit, leadership dynamics, management depth, decision-making and adaptability.
Are priorities sufficiently clear?
Investment thesis, strategic priorities, execution roadmap, trade-offs, accountabilities and alignment between shareholders, Board and management.
Can the organization execute effectively?
Structure, operating model, roles, decision rights, interfaces, management routines, processes and critical bottlenecks.
Are behaviours supporting performance?
Accountability, engagement, key talent, retention, management practices, collaboration and capacity for change.
Portfolio Execution Review or Organizational Assessment?
The scope depends on the question that needs to be answered.
Starts with the investor’s performance question.
Why is this portfolio company not delivering as expected, what is materially constraining value creation and what decision should investors or the Board consider?
Starts with the organization’s capacity to execute.
What leadership and organizational factors need to change or strengthen during growth, transformation or underperformance?
How We Work
A focused and independent process designed to move quickly from symptoms to evidence, root causes and decisions.
Clarify investor and Board concerns, business performance, existing hypotheses and the decisions the review needs to inform.
Interview the CEO, executive team, relevant managers, investors, Board members and other stakeholders as required.
Use business data, organizational evidence, questionnaires, psychometrics or broader employee input where they materially improve the diagnosis.
Triangulate findings and translate them into root causes, risks, decisions and priority actions.
What Investors Receive
A decision-ready perspective on what is limiting execution and what should happen next.
- What is actually driving underperformance
- Leadership and governance issues
- Organizational bottlenecks
- Strategic alignment gaps
- Culture and talent risks
- CEO and executive-team effectiveness
- Critical capability gaps
- Governance and decision quality
- Operating-model limitations
- Execution capacity
- Issues requiring immediate attention
- Leadership and governance decisions
- Organizational actions
- What should not be changed
- Follow-up and monitoring priorities
The Decisions a Review Can Inform
The review is useful only if it helps investors and Boards decide what to do next.
- Support and develop the existing CEO.
- Strengthen or reconfigure the executive team.
- Prepare a CEO or leadership transition.
- Clarify governance and Board-management interfaces.
- Resolve a critical function or business-unit issue.
- Redesign part of the organization or operating model.
- Reduce or reprioritize strategic initiatives.
- Strengthen management depth and accountability.
- Address critical talent or retention risks.
- Define what investors should monitor next.
One Portfolio Company or Several
The same decision-oriented approach can be applied selectively across a portfolio.
A focused review of one company when performance, leadership or execution concerns require an independent diagnosis.
A common framework applied selectively across several companies to identify recurring risks and prioritize investor attention.
Relevant Experience
Independent reviews have informed decisions in underperformance, leadership, crisis and organizational situations.
See examples of WINGMIND assignments involving portfolio underperformance, CEO questions, organizational breakdown and critical leadership decisions.
Why WINGMIND?
An investor, entrepreneurial and leadership perspective on portfolio company execution.
Founded by a former private equity investor, WINGMIND understands investment theses, Board dynamics, execution risk and the decisions shareholders face when performance deteriorates.
We connect leadership, strategy, organization, governance, culture and talent rather than assuming the problem sits in one dimension.
The objective is not another report. It is to give investors and Boards the evidence and perspective required to make a better decision.
100+ engagements across 10 countries, combining investment, entrepreneurial, leadership and organizational experience.
Frequently Asked Questions
Key questions about Portfolio Execution Reviews.
What is a Portfolio Execution Review?
A Portfolio Execution Review is an independent assessment of the leadership, strategic, organizational and human factors that may be limiting a portfolio company’s ability to execute its plan and create value. It is designed to clarify root causes and support investor and Board decisions.
When should investors launch a review?
A review is particularly useful when a company repeatedly misses its plan, execution slows, confidence in leadership declines or a significant leadership or organizational decision is being considered.
Is this a financial or operational audit?
No. Financial and operational performance provide important evidence, but the review focuses on the leadership, strategic, governance and organizational factors behind execution.
Does management participate?
Yes. The CEO and selected executives are normally involved, alongside investors, Board members and other stakeholders where relevant. The objective is to triangulate perspectives rather than rely on one diagnosis.
How long does a Portfolio Execution Review take?
A focused review can generally be completed within two to four weeks, depending on the scope, number of stakeholders and complexity of the situation.
Can the review focus specifically on the CEO or executive team?
Yes. If the question is primarily a leadership question, the work can incorporate or lead to a focused Executive Assessment or Executive Team Assessment.
Can WINGMIND support implementation after the review?
Yes. Depending on the conclusions, support may include CEO & Board Advisory, leadership assessment, executive coaching, executive-team work or targeted organizational support.
Related Approaches
The appropriate intervention depends on the question and stage of the investment.
Discuss a Portfolio Company
Is a portfolio company no longer delivering as expected, or are you considering a critical leadership or organizational decision? A confidential conversation can help clarify the question and the appropriate scope.
Email: contact@wingmind.co
LinkedIn: David Chouraqui
Book a call: Schedule a confidential conversation
Founded by David Chouraqui, former private equity investor and entrepreneur, WINGMIND supports PE, Growth & VC investors and portfolio companies on the human and organizational factors that shape execution and value creation.